搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
来自MSN
4 小时
AbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpoint
The company plans to submit a new drug application for tavapadon to the US Food and Drug Administration next year.
Zacks.com on MSN
5 小时
AbbVie's Recently Acquired Parkinson's Drug Meets Third Study Goal
AbbVie ABBV announced positive top-line results from the pivotal phase III TEMPO-2 study, which evaluated its recently ...
Outsourcing-pharma
7 小时
AbbVie’s monotherapy achieves positive phase 3 results
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Murder suspect charged
Ambassador to Mexico?
Announces new monument
World Series champion dies
Gets 50 years in prison
Tyson faces $1.5M suit
Haiti gangs kill 180+
Time's Athlete of the Year
1/3 of older adults lonely?
CA warnings on social sites
Lands talk show on OANN
US, UK target gold scheme
DOJ: Violated civil rights
Emergency brain surgery
Utah environmental dispute
US indicts ex-Syrian officials
Boeing layoffs continue
US renews push to find Tice
Read's second trial delayed
ISR warplanes pound Syria
Seek Senate support
Orbán meets Trump, Musk
Labor costs revised down
Launches AI video generator
Hawaii gun case rejected
Wildfire forces evacuations
FTC issuing refunds
2024 best-managed firms
Alaska oil & gas auction set
NFL streaming record set
Famed poet Giovanni dies
反馈